102 related articles for article (PubMed ID: 27252517)
21. Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation.
Zenke S; Sica MP; Steinberg F; Braun J; Zink A; Gavrilov A; Hilger A; Arra A; Brunner-Weinzierl M; Elling R; Beyersdorf N; Lämmermann T; Smulski CR; Rohr JC
Nat Commun; 2022 Oct; 13(1):6459. PubMed ID: 36309492
[TBL] [Abstract][Full Text] [Related]
22. Regulation of surface and intracellular expression of CTLA4 on mouse T cells.
Alegre ML; Noel PJ; Eisfelder BJ; Chuang E; Clark MR; Reiner SL; Thompson CB
J Immunol; 1996 Dec; 157(11):4762-70. PubMed ID: 8943377
[TBL] [Abstract][Full Text] [Related]
23. Regulation of CTLA-4 expression during T cell activation.
Perkins D; Wang Z; Donovan C; He H; Mark D; Guan G; Wang Y; Walunas T; Bluestone J; Listman J; Finn PW
J Immunol; 1996 Jun; 156(11):4154-9. PubMed ID: 8666782
[TBL] [Abstract][Full Text] [Related]
24. Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
Karabon L; Tupikowski K; Tomkiewicz A; Partyka A; Pawlak-Adamska E; Wojciechowski A; Kolodziej A; Dembowski J; Zdrojowy R; Frydecka I
Pathol Oncol Res; 2017 Oct; 23(4):837-843. PubMed ID: 28101800
[TBL] [Abstract][Full Text] [Related]
25. An Mse I RFLP in the human CTLA4 promotor.
Deichmann K; Heinzmann A; Brüggenolte E; Forster J; Kuehr J
Biochem Biophys Res Commun; 1996 Aug; 225(3):817-8. PubMed ID: 8780695
[TBL] [Abstract][Full Text] [Related]
26. Blockade of CD28/B7 interaction suppresses allergic eosinophilic inflammation in mice.
Kasai M; Kumano K; Kurasawa K; Nakao A; Saito Y; Iwamoto I
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():14-9. PubMed ID: 9758890
[TBL] [Abstract][Full Text] [Related]
27. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
[TBL] [Abstract][Full Text] [Related]
28. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activation.
Mäurer M; Loserth S; Kolb-Mäurer A; Ponath A; Wiese S; Kruse N; Rieckmann P
Immunogenetics; 2002 Apr; 54(1):1-8. PubMed ID: 11976786
[TBL] [Abstract][Full Text] [Related]
29. CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.
Hueber AJ; Matzkies FG; Rahmeh M; Manger B; Kalden JR; Nagel T
Immunol Cell Biol; 2006 Feb; 84(1):51-8. PubMed ID: 16405652
[TBL] [Abstract][Full Text] [Related]
30. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
Lane P; Haller C; McConnell F
Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
[TBL] [Abstract][Full Text] [Related]
31. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
32. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.
Harper K; Balzano C; Rouvier E; Mattéi MG; Luciani MF; Golstein P
J Immunol; 1991 Aug; 147(3):1037-44. PubMed ID: 1713603
[TBL] [Abstract][Full Text] [Related]
33. B70 antigen is a second ligand for CTLA-4 and CD28.
Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
[TBL] [Abstract][Full Text] [Related]
34. Characterization of CTLA-4 structure and expression on human T cells.
Lindsten T; Lee KP; Harris ES; Petryniak B; Craighead N; Reynolds PJ; Lombard DB; Freeman GJ; Nadler LM; Gray GS
J Immunol; 1993 Oct; 151(7):3489-99. PubMed ID: 8397258
[TBL] [Abstract][Full Text] [Related]
35. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches.
Ling V; Wu PW; Finnerty HF; Agostino MJ; Graham JR; Chen S; Jussiff JM; Fisk GJ; Miller CP; Collins M
Genomics; 2001 Dec; 78(3):155-68. PubMed ID: 11735222
[TBL] [Abstract][Full Text] [Related]
36. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
[TBL] [Abstract][Full Text] [Related]
37. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.
Nagaraju K; Raben N; Villalba ML; Danning C; Loeffler LA; Lee E; Tresser N; Abati A; Fetsch P; Plotz PH
Clin Immunol; 1999 Aug; 92(2):161-9. PubMed ID: 10444360
[TBL] [Abstract][Full Text] [Related]
38. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
[TBL] [Abstract][Full Text] [Related]
39. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
40. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease.
Green JM
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):261-4. PubMed ID: 10696061
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
